Evidence map›Paper›PMID 37091214›Full record

ArticleGynecologic oncology reports2023

The association between TIPARP gene polymorphisms rs2665390 and ovarian cancer susceptibility.

Maryam Vahidi, Massoud Houshmand, Mahdieh Banoei, Farid Heidari

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gynecologic oncology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Maryam VahidiDepartment of Medical Genetics, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
Massoud HoushmandDepartment of Medical Genetics, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
Mahdieh BanoeiDepartment of Molecular Medicine, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
Farid HeidariDepartment of Animal Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.
National Institute of Genetic Engineering and Biotechnology · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovarian cancer is taken as the most typical malignancy among women and the ninth most typical cancer in Iran. Predictive tools are of great importance as ovarian cancer is usually detected in patients at later stages of the disease. In other countries, the

Indexed as

Ovarian cancerRs2665390Single nucleotide polymorphismTetra-ARMs PCRTIPARP gene

Identifiers

PMID37091214
PMCPMC10113771
OpenAlexW4362576147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.